{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:25:34Z","timestamp":1769732734080,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.oftale.2025.502430","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:57:09Z","timestamp":1765007829000},"page":"502430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New horizons in the treatment of non-infectious uveitis"],"prefix":"10.1016","volume":"101","author":[{"given":"A.","family":"Fonollosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2025.502430_bib0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for Uveitis (FOCUS) initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2025.502430_bib0010","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/ard-2024-225933","article-title":"Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b\/3 trials","volume":"83","author":"Brown","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"Pt 2","key":"10.1016\/j.oftale.2025.502430_bib0015","article-title":"Interleukin-6 in non-infectious uveitis: biology, experimental evidence and treatment strategies","volume":"230","author":"Yu","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.oftale.2025.502430_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajo.2017.08.019","article-title":"Primary (month-6) outcomes of the STOP-uveitis study: evaluating the safety, tolerability, and efficacy of tocilizumab in patients with noninfectious uveitis","volume":"183","author":"Sepah","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2025.502430_bib0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ophtha.2018.09.044","article-title":"Efficacy and safety of sarilumab for the treatment of posterior segment noninfectious uveitis (SARIL-NIU):: the phase 2 SATURN study","volume":"126","author":"Heissigerov\u00e1","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2025.502430_bib0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/IAE.0000000000001690","article-title":"Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema","volume":"38","author":"Mesquida","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2025.502430_bib0035","unstructured":"Pavesio C, Suhler E, Lin P, Pauly-Evers M, Willen D, Holmes W, Storti F, Barekati Z, Gott T, Passemard B, Macgregor L, Sharma S, Fauser S, Mesquida M. Intravitreal Interleukin-6 Inhibition With Vamikibart in Uveitic Macular Edema: Final Results From the Phase 1 DOVETAIL Study. 24th EURETINA Congress Barcelona, Spain | 19-22 September 2024."},{"key":"10.1016\/j.oftale.2025.502430_bib0040","unstructured":"ClinicalTrials.gov Identifier: MEERKAT (NCT05642312); SANDCAT(NCT05642325). Fonollosa A; Steeples L; Elze MC; Macgregor L; Stoilov I; Silverman D; Mesquida M; Z Haskova Z,Suhler E. L-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Study Design of the Phase 3 MEERKAT and SANDCAT Trials. Presentado en el 24 Congreso de Euretina | Barcelona, Espa\u00f1a | 19-22 Septiembre 2024."},{"key":"10.1016\/j.oftale.2025.502430_bib0045","article-title":"Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries","volume":"11","author":"Vitale","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oftale.2025.502430_bib0050","series-title":"PR Newswire: press release distribution, targeting, monitoring and marketing","article-title":"Priovant Therapeutics Announces Positive Phase 2 neptune study results for Brepocitinib in non-infectious uveitis (NIU), showing strongest efficacy data in NIU observed to date","author":"Therapeutics","year":"2024"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357942500204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357942500204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:52:38Z","timestamp":1769691158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357942500204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S217357942500204X"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2025.502430","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New horizons in the treatment of non-infectious uveitis","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2025.502430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2025.502430","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502430"}}